Industry: Consumer Goods
Published Date: 2025-01-31
Pages: 136 Pages
Report ld: 3631708
Request Sample
Customized Report
Nicotinamide Ribose Supplement Market Size(US$)

CAGR 2025-2031
6.8%
Market Size,2031
USD 638
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
North American market for Nicotinamide Ribose Supplement was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Nicotinamide Ribose Supplement was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Nicotinamide Ribose Supplement was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Nicotinamide Ribose Supplement include Jarrow, Codeage, Tru Niagen, The major vendors covered:, Chroma Dex, Elysium Health, Natural Nutra, Thorne, Zhejiang Jiahua Pharmchemical, Shenzhen Longgesheng Technology, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Nicotinamide Ribose Supplement, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nicotinamide Ribose Supplement by region & country, by Type, and by Application.
The Nicotinamide Ribose Supplement market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Ribose Supplement.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nicotinamide Ribose Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nicotinamide Ribose Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nicotinamide Ribose Supplement in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Nicotinamide Ribose Supplement Product Introduction
1.2 Global Nicotinamide Ribose Supplement Market Size Forecast
1.2.1 Global Nicotinamide Ribose Supplement Sales Value (2020-2031)
1.2.2 Global Nicotinamide Ribose Supplement Sales Volume (2020-2031)
1.2.3 Global Nicotinamide Ribose Supplement Sales Price (2020-2031)
1.3 Nicotinamide Ribose Supplement Market Trends & Drivers
1.3.1 Nicotinamide Ribose Supplement Industry Trends
1.3.2 Nicotinamide Ribose Supplement Market Drivers & Opportunity
1.3.3 Nicotinamide Ribose Supplement Market Challenges
1.3.4 Nicotinamide Ribose Supplement Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nicotinamide Ribose Supplement Players Revenue Ranking (2024)
2.2 Global Nicotinamide Ribose Supplement Revenue by Company (2020-2025)
2.3 Global Nicotinamide Ribose Supplement Players Sales Volume Ranking (2024)
2.4 Global Nicotinamide Ribose Supplement Sales Volume by Company Players (2020-2025)
2.5 Global Nicotinamide Ribose Supplement Average Price by Company (2020-2025)
2.6 Key Manufacturers Nicotinamide Ribose Supplement Manufacturing Base and Headquarters
2.7 Key Manufacturers Nicotinamide Ribose Supplement Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nicotinamide Ribose Supplement
2.9 Nicotinamide Ribose Supplement Market Competitive Analysis
2.9.1 Nicotinamide Ribose Supplement Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Nicotinamide Ribose Supplement Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Ribose Supplement as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pharmaceutical Grade
3.1.2 Food Grade
3.1.3 Others
3.2 Global Nicotinamide Ribose Supplement Sales Value by Type
3.2.1 Global Nicotinamide Ribose Supplement Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Nicotinamide Ribose Supplement Sales Value, by Type (2020-2031)
3.2.3 Global Nicotinamide Ribose Supplement Sales Value, by Type (%) (2020-2031)
3.3 Global Nicotinamide Ribose Supplement Sales Volume by Type
3.3.1 Global Nicotinamide Ribose Supplement Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Nicotinamide Ribose Supplement Sales Volume, by Type (2020-2031)
3.3.3 Global Nicotinamide Ribose Supplement Sales Volume, by Type (%) (2020-2031)
3.4 Global Nicotinamide Ribose Supplement Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food Industry
4.1.2 Pharmaceutical Industry
4.1.3 Others
4.2 Global Nicotinamide Ribose Supplement Sales Value by Application
4.2.1 Global Nicotinamide Ribose Supplement Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Nicotinamide Ribose Supplement Sales Value, by Application (2020-2031)
4.2.3 Global Nicotinamide Ribose Supplement Sales Value, by Application (%) (2020-2031)
4.3 Global Nicotinamide Ribose Supplement Sales Volume by Application
4.3.1 Global Nicotinamide Ribose Supplement Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Nicotinamide Ribose Supplement Sales Volume, by Application (2020-2031)
4.3.3 Global Nicotinamide Ribose Supplement Sales Volume, by Application (%) (2020-2031)
4.4 Global Nicotinamide Ribose Supplement Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Nicotinamide Ribose Supplement Sales Value by Region
5.1.1 Global Nicotinamide Ribose Supplement Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Nicotinamide Ribose Supplement Sales Value by Region (2020-2025)
5.1.3 Global Nicotinamide Ribose Supplement Sales Value by Region (2026-2031)
5.1.4 Global Nicotinamide Ribose Supplement Sales Value by Region (%), (2020-2031)
5.2 Global Nicotinamide Ribose Supplement Sales Volume by Region
5.2.1 Global Nicotinamide Ribose Supplement Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Nicotinamide Ribose Supplement Sales Volume by Region (2020-2025)
5.2.3 Global Nicotinamide Ribose Supplement Sales Volume by Region (2026-2031)
5.2.4 Global Nicotinamide Ribose Supplement Sales Volume by Region (%), (2020-2031)
5.3 Global Nicotinamide Ribose Supplement Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Nicotinamide Ribose Supplement Sales Value, 2020-2031
5.4.2 North America Nicotinamide Ribose Supplement Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Nicotinamide Ribose Supplement Sales Value, 2020-2031
5.5.2 Europe Nicotinamide Ribose Supplement Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Nicotinamide Ribose Supplement Sales Value, 2020-2031
5.6.2 Asia Pacific Nicotinamide Ribose Supplement Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Nicotinamide Ribose Supplement Sales Value, 2020-2031
5.7.2 South America Nicotinamide Ribose Supplement Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nicotinamide Ribose Supplement Sales Value, 2020-2031
5.8.2 Middle East & Africa Nicotinamide Ribose Supplement Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nicotinamide Ribose Supplement Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Nicotinamide Ribose Supplement Sales Value
6.2.1 Key Countries/Regions Nicotinamide Ribose Supplement Sales Value, 2020-2031
6.2.2 Key Countries/Regions Nicotinamide Ribose Supplement Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Nicotinamide Ribose Supplement Sales Value, 2020-2031
6.3.2 United States Nicotinamide Ribose Supplement Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Nicotinamide Ribose Supplement Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Nicotinamide Ribose Supplement Sales Value, 2020-2031
6.4.2 Europe Nicotinamide Ribose Supplement Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Nicotinamide Ribose Supplement Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Nicotinamide Ribose Supplement Sales Value, 2020-2031
6.5.2 China Nicotinamide Ribose Supplement Sales Value by Type (%), 2024 VS 2031
6.5.3 China Nicotinamide Ribose Supplement Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Nicotinamide Ribose Supplement Sales Value, 2020-2031
6.6.2 Japan Nicotinamide Ribose Supplement Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Nicotinamide Ribose Supplement Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Nicotinamide Ribose Supplement Sales Value, 2020-2031
6.7.2 South Korea Nicotinamide Ribose Supplement Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Nicotinamide Ribose Supplement Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Nicotinamide Ribose Supplement Sales Value, 2020-2031
6.8.2 Southeast Asia Nicotinamide Ribose Supplement Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Nicotinamide Ribose Supplement Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Nicotinamide Ribose Supplement Sales Value, 2020-2031
6.9.2 India Nicotinamide Ribose Supplement Sales Value by Type (%), 2024 VS 2031
6.9.3 India Nicotinamide Ribose Supplement Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Jarrow
7.1.1 Jarrow Company Information
7.1.2 Jarrow Introduction and Business Overview
7.1.3 Jarrow Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Jarrow Nicotinamide Ribose Supplement Product Offerings
7.1.5 Jarrow Recent Development
7.2 Codeage
7.2.1 Codeage Company Information
7.2.2 Codeage Introduction and Business Overview
7.2.3 Codeage Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Codeage Nicotinamide Ribose Supplement Product Offerings
7.2.5 Codeage Recent Development
7.3 Tru Niagen
7.3.1 Tru Niagen Company Information
7.3.2 Tru Niagen Introduction and Business Overview
7.3.3 Tru Niagen Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Tru Niagen Nicotinamide Ribose Supplement Product Offerings
7.3.5 Tru Niagen Recent Development
7.4 The major vendors covered:
7.4.1 The major vendors covered: Company Information
7.4.2 The major vendors covered: Introduction and Business Overview
7.4.3 The major vendors covered: Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 The major vendors covered: Nicotinamide Ribose Supplement Product Offerings
7.4.5 The major vendors covered: Recent Development
7.5 Chroma Dex
7.5.1 Chroma Dex Company Information
7.5.2 Chroma Dex Introduction and Business Overview
7.5.3 Chroma Dex Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Chroma Dex Nicotinamide Ribose Supplement Product Offerings
7.5.5 Chroma Dex Recent Development
7.6 Elysium Health
7.6.1 Elysium Health Company Information
7.6.2 Elysium Health Introduction and Business Overview
7.6.3 Elysium Health Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Elysium Health Nicotinamide Ribose Supplement Product Offerings
7.6.5 Elysium Health Recent Development
7.7 Natural Nutra
7.7.1 Natural Nutra Company Information
7.7.2 Natural Nutra Introduction and Business Overview
7.7.3 Natural Nutra Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Natural Nutra Nicotinamide Ribose Supplement Product Offerings
7.7.5 Natural Nutra Recent Development
7.8 Thorne
7.8.1 Thorne Company Information
7.8.2 Thorne Introduction and Business Overview
7.8.3 Thorne Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Thorne Nicotinamide Ribose Supplement Product Offerings
7.8.5 Thorne Recent Development
7.9 Zhejiang Jiahua Pharmchemical
7.9.1 Zhejiang Jiahua Pharmchemical Company Information
7.9.2 Zhejiang Jiahua Pharmchemical Introduction and Business Overview
7.9.3 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose Supplement Product Offerings
7.9.5 Zhejiang Jiahua Pharmchemical Recent Development
7.10 Shenzhen Longgesheng Technology
7.10.1 Shenzhen Longgesheng Technology Company Information
7.10.2 Shenzhen Longgesheng Technology Introduction and Business Overview
7.10.3 Shenzhen Longgesheng Technology Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Shenzhen Longgesheng Technology Nicotinamide Ribose Supplement Product Offerings
7.10.5 Shenzhen Longgesheng Technology Recent Development
7.11 Bontac Bio-engineering
7.11.1 Bontac Bio-engineering Company Information
7.11.2 Bontac Bio-engineering Introduction and Business Overview
7.11.3 Bontac Bio-engineering Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Bontac Bio-engineering Nicotinamide Ribose Supplement Product Offerings
7.11.5 Bontac Bio-engineering Recent Development
7.12 Springtide
7.12.1 Springtide Company Information
7.12.2 Springtide Introduction and Business Overview
7.12.3 Springtide Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Springtide Nicotinamide Ribose Supplement Product Offerings
7.12.5 Springtide Recent Development
7.13 Solaray
7.13.1 Solaray Company Information
7.13.2 Solaray Introduction and Business Overview
7.13.3 Solaray Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Solaray Nicotinamide Ribose Supplement Product Offerings
7.13.5 Solaray Recent Development
7.14 Life Extension
7.14.1 Life Extension Company Information
7.14.2 Life Extension Introduction and Business Overview
7.14.3 Life Extension Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Life Extension Nicotinamide Ribose Supplement Product Offerings
7.14.5 Life Extension Recent Development
7.15 ChromaDex Corporation
7.15.1 ChromaDex Corporation Company Information
7.15.2 ChromaDex Corporation Introduction and Business Overview
7.15.3 ChromaDex Corporation Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 ChromaDex Corporation Nicotinamide Ribose Supplement Product Offerings
7.15.5 ChromaDex Corporation Recent Development
7.16 Thorne Research
7.16.1 Thorne Research Company Information
7.16.2 Thorne Research Introduction and Business Overview
7.16.3 Thorne Research Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Thorne Research Nicotinamide Ribose Supplement Product Offerings
7.16.5 Thorne Research Recent Development
7.17 Tesseract Medical Research
7.17.1 Tesseract Medical Research Company Information
7.17.2 Tesseract Medical Research Introduction and Business Overview
7.17.3 Tesseract Medical Research Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Tesseract Medical Research Nicotinamide Ribose Supplement Product Offerings
7.17.5 Tesseract Medical Research Recent Development
7.18 Biotrend Chemikalien
7.18.1 Biotrend Chemikalien Company Information
7.18.2 Biotrend Chemikalien Introduction and Business Overview
7.18.3 Biotrend Chemikalien Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Biotrend Chemikalien Nicotinamide Ribose Supplement Product Offerings
7.18.5 Biotrend Chemikalien Recent Development
7.19 Vitacost.com
7.19.1 Vitacost.com Company Information
7.19.2 Vitacost.com Introduction and Business Overview
7.19.3 Vitacost.com Nicotinamide Ribose Supplement Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Vitacost.com Nicotinamide Ribose Supplement Product Offerings
7.19.5 Vitacost.com Recent Development
8 Industry Chain Analysis
8.1 Nicotinamide Ribose Supplement Industrial Chain
8.2 Nicotinamide Ribose Supplement Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nicotinamide Ribose Supplement Sales Model
8.5.2 Sales Channel
8.5.3 Nicotinamide Ribose Supplement Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 430 million in 2025 and is projected to reach US$ 677 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 153
USD 3950.00
(Single User License)
The global Nicotinamide Ribose Supplement market was valued at US$ 430 million in 2025 and is anticipated to reach US$ 677 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-04-19
Pages: 132
USD 2900.00
(Single User License)
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 405 million in 2024 to US$ 638 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-17
Pages: 179
USD 4900.00
(Single User License)
The global Nicotinamide Ribose Supplement market size was US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 102
USD 4250.00
(Single User License)
The global market for Nicotinamide Ribose Supplement was valued at US$ 405 million in the year 2024 and is projected to reach a revised size of US$ 638 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-01-31
Pages: 102
USD 2900.00
(Single User License)
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 382 million in 2024 to US$ 566.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published Date: 2024-04-09
Pages: 114
USD 4900.00
(Single User License)
The global Nicotinamide Ribose Supplement market was valued at US$ 361 million in 2023 and is anticipated to reach US$ 566.9 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
Published Date: 2024-01-18
Pages: 106
USD 2900.00
(Single User License)
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 430 million in 2025 and is projected to reach US$ 677 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 153
The global Nicotinamide Ribose Supplement market was valued at US$ 430 million in 2025 and is anticipated to reach US$ 677 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-04-19
Pages: 132
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 405 million in 2024 to US$ 638 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-17
Pages: 179
The global Nicotinamide Ribose Supplement market size was US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 102
The global market for Nicotinamide Ribose Supplement was valued at US$ 405 million in the year 2024 and is projected to reach a revised size of US$ 638 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-01-31
Pages: 102
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 382 million in 2024 to US$ 566.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published: 2024-04-09
Pages: 114
The global Nicotinamide Ribose Supplement market was valued at US$ 361 million in 2023 and is anticipated to reach US$ 566.9 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 106
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now